OP
Oriol Pich
The Francis Crick Institute, Centre de Regulació Genòmica, Universitat de Barcelona Facultat de Medicina, Institut de Recerca Biomèdica
Research areas: Biochemistry, Genetics and Molecular Biology · Cancer Research · Cancer Genomics and Diagnostics · Chromatin Remodeling and Cancer · Cancer Immunotherapy and Biomarkers
0000-0002-1956-1882
Employment
-
The Francis Crick Institute Senior Bionformatics Scientist2020 - Present
-
Institut de Recerca Biomèdica PhD Candidate2016 - 2020
-
Centre de Regulació Genòmica2013 - Present
Education
-
Universitat de Barcelona Facultat de Medicina2010 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (47)
- Context-dependent selection sculpts mutational landscapes in the normal lung Save
- Somatic evolution following cancer treatment in normal tissue Save
- Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy Save
- ImmuneLENS characterizes systemic immune dysregulation in aging and cancer Save
- TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling Save
- Origins and impact of extrachromosomal DNA Save
- MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution Save
- Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution Save
- Data from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Data from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 1 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 1 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 2 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 2 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 3 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 3 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 4 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 4 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 5 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save
- Figure 5 from Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer Save